Temozolomide: Package Insert and Label Information (Page 5 of 5)

NDC 65162-805-51

Temozolomide Capsules USP, 180 mg

Rx only

5 Capsules

Amneal Pharmaceuticals LLC

11
(click image for full-size original)
12
(click image for full-size original)

NDC 65162-806-51
Temozolomide Capsules USP, 250 mg
Rx only
5 Capsules
Amneal Pharmaceuticals LLC

11
(click image for full-size original)
12
(click image for full-size original)

TEMOZOLOMIDE temozolomide capsule
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:65162-801
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TEMOZOLOMIDE (TEMOZOLOMIDE) TEMOZOLOMIDE 5 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
ALCOHOL
ANHYDROUS LACTOSE
SODIUM STARCH GLYCOLATE TYPE A POTATO
STEARIC ACID
TARTARIC ACID
GELATIN
TITANIUM DIOXIDE
D&C YELLOW NO. 10
FD&C BLUE NO. 1
FD&C BLUE NO. 2
FD&C RED NO. 40
FERROSOFERRIC OXIDE
BUTYL ALCOHOL
PROPYLENE GLYCOL
SHELLAC
FERRIC OXIDE YELLOW
Product Characteristics
Color white (opaque) , green (opaque) Score no score
Shape CAPSULE Size 16mm
Flavor Imprint Code AMNEAL;801
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:65162-801-51 1 BOTTLE in 1 CARTON contains a BOTTLE
1 5 CAPSULE in 1 BOTTLE This package is contained within the CARTON (65162-801-51)
2 NDC:65162-801-14 1 BOTTLE in 1 CARTON contains a BOTTLE
2 14 CAPSULE in 1 BOTTLE This package is contained within the CARTON (65162-801-14)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA203691 04/03/2015
TEMOZOLOMIDE temozolomide capsule
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:65162-802
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TEMOZOLOMIDE (TEMOZOLOMIDE) TEMOZOLOMIDE 20 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
ANHYDROUS LACTOSE
SODIUM STARCH GLYCOLATE TYPE A POTATO
STEARIC ACID
TARTARIC ACID
GELATIN
TITANIUM DIOXIDE
ALCOHOL
D&C YELLOW NO. 10
FD&C BLUE NO. 1
FD&C BLUE NO. 2
FD&C RED NO. 40
FERROSOFERRIC OXIDE
BUTYL ALCOHOL
PROPYLENE GLYCOL
SHELLAC
FD&C YELLOW NO. 6
Product Characteristics
Color yellow (opaque) , white (opaque) Score no score
Shape CAPSULE Size 18mm
Flavor Imprint Code AMNEAL;802
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:65162-802-51 1 BOTTLE in 1 CARTON contains a BOTTLE
1 5 CAPSULE in 1 BOTTLE This package is contained within the CARTON (65162-802-51)
2 NDC:65162-802-14 1 BOTTLE in 1 CARTON contains a BOTTLE
2 14 CAPSULE in 1 BOTTLE This package is contained within the CARTON (65162-802-14)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA203691 04/03/2015
TEMOZOLOMIDE temozolomide capsule
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:65162-803
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TEMOZOLOMIDE (TEMOZOLOMIDE) TEMOZOLOMIDE 100 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
ANHYDROUS LACTOSE
SODIUM STARCH GLYCOLATE TYPE A POTATO
STEARIC ACID
TARTARIC ACID
GELATIN
TITANIUM DIOXIDE
ALCOHOL
D&C YELLOW NO. 10
FD&C BLUE NO. 1
FD&C BLUE NO. 2
FD&C RED NO. 40
FERROSOFERRIC OXIDE
BUTYL ALCOHOL
PROPYLENE GLYCOL
SHELLAC
FD&C RED NO. 3
Product Characteristics
Color white (opaque) , pink (opaque) Score no score
Shape CAPSULE Size 19mm
Flavor Imprint Code AMNEAL;803
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:65162-803-51 1 BOTTLE in 1 CARTON contains a BOTTLE
1 5 CAPSULE in 1 BOTTLE This package is contained within the CARTON (65162-803-51)
2 NDC:65162-803-14 1 BOTTLE in 1 CARTON contains a BOTTLE
2 14 CAPSULE in 1 BOTTLE This package is contained within the CARTON (65162-803-14)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA203691 04/03/2015
TEMOZOLOMIDE temozolomide capsule
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:65162-804
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TEMOZOLOMIDE (TEMOZOLOMIDE) TEMOZOLOMIDE 140 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
ANHYDROUS LACTOSE
SODIUM STARCH GLYCOLATE TYPE A POTATO
STEARIC ACID
TARTARIC ACID
GELATIN
TITANIUM DIOXIDE
ALCOHOL
D&C YELLOW NO. 10
FD&C BLUE NO. 1
FD&C BLUE NO. 2
FD&C RED NO. 40
FERROSOFERRIC OXIDE
BUTYL ALCOHOL
PROPYLENE GLYCOL
SHELLAC
Product Characteristics
Color white (opaque) , blue (opaque) Score no score
Shape CAPSULE Size 22mm
Flavor Imprint Code AMNEAL;804
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:65162-804-51 1 BOTTLE in 1 CARTON contains a BOTTLE
1 5 CAPSULE in 1 BOTTLE This package is contained within the CARTON (65162-804-51)
2 NDC:65162-804-14 1 BOTTLE in 1 CARTON contains a BOTTLE
2 14 CAPSULE in 1 BOTTLE This package is contained within the CARTON (65162-804-14)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA203691 04/03/2015
TEMOZOLOMIDE temozolomide capsule
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:65162-805
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TEMOZOLOMIDE (TEMOZOLOMIDE) TEMOZOLOMIDE 180 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
ANHYDROUS LACTOSE
SODIUM STARCH GLYCOLATE TYPE A POTATO
STEARIC ACID
TARTARIC ACID
GELATIN
TITANIUM DIOXIDE
ALCOHOL
D&C YELLOW NO. 10
FD&C BLUE NO. 1
FD&C BLUE NO. 2
FD&C RED NO. 40
FERROSOFERRIC OXIDE
BUTYL ALCOHOL
PROPYLENE GLYCOL
SHELLAC
Product Characteristics
Color white (opaque) , red (opaque) Score no score
Shape CAPSULE Size 22mm
Flavor Imprint Code AMNEAL;805
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:65162-805-51 1 BOTTLE in 1 CARTON contains a BOTTLE
1 5 CAPSULE in 1 BOTTLE This package is contained within the CARTON (65162-805-51)
2 NDC:65162-805-14 1 BOTTLE in 1 CARTON contains a BOTTLE
2 14 CAPSULE in 1 BOTTLE This package is contained within the CARTON (65162-805-14)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA203691 04/03/2015
TEMOZOLOMIDE temozolomide capsule
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:65162-806
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TEMOZOLOMIDE (TEMOZOLOMIDE) TEMOZOLOMIDE 250 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
ANHYDROUS LACTOSE
SODIUM STARCH GLYCOLATE TYPE A POTATO
STEARIC ACID
TARTARIC ACID
GELATIN
TITANIUM DIOXIDE
ALCOHOL
D&C YELLOW NO. 10
FD&C BLUE NO. 1
FD&C BLUE NO. 2
FD&C RED NO. 40
FERROSOFERRIC OXIDE
BUTYL ALCOHOL
PROPYLENE GLYCOL
SHELLAC
Product Characteristics
Color white (opaque) Score no score
Shape CAPSULE Size 22mm
Flavor Imprint Code AMNEAL;806
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:65162-806-51 1 BOTTLE in 1 CARTON contains a BOTTLE
1 5 CAPSULE in 1 BOTTLE This package is contained within the CARTON (65162-806-51)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA203691 04/03/2015
Labeler — Amneal Pharmaceuticals LLC (123797875)
Establishment
Name Address ID/FEI Operations
Amneal Pharmaceuticals of New York, LLC 123797875 analysis (65162-801), analysis (65162-802), analysis (65162-803), analysis (65162-804), analysis (65162-805), analysis (65162-806), label (65162-801), label (65162-802), label (65162-803), label (65162-804), label (65162-805), label (65162-806), manufacture (65162-801), manufacture (65162-802), manufacture (65162-803), manufacture (65162-804), manufacture (65162-805), manufacture (65162-806), pack (65162-801), pack (65162-802), pack (65162-803), pack (65162-804), pack (65162-805), pack (65162-806)

Revised: 01/2022 Amneal Pharmaceuticals LLC

DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.

https://druginserts.com/lib/rx/meds/temozolomide-18/page/5/

Clinical Trials

DrugInserts.com

Information Sections

RSS Feeds

About

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2023. All Rights Reserved.